Antoine Boutin-Paradis

Antoine Boutin-Paradis

Auto-generated profile, based on publicly available information

Antoine Boutin-Paradis

Université Grenoble Alpes, INSERM U1300, CHU Grenoble Alpes, HP2 Grenoble France

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
MMMélanie Kotzki Minoves
Mélanie Kotzki Minoves
FPFlorence PUCH
Florence PUCH
GMGiorgia Moriondo
Giorgia Moriondo
ABAntoine Boutin-Paradis
Antoine Boutin-Paradis
ELEmeline Lemarié
Emeline Lemarié
ABAnne Briançon-Marjollet
Anne Briançon-Marjollet
Obstructive sleep apnea (OSA) is an emerging risk factor for cancer occurrence and progression, mainly mediated by intermittent hypoxia (IH). Systemic IH, a main landmark of OSA, and local sustained hypoxia (SH), a classical feature at the core of tumors, may act separately or synergistically on tumor cells. Our aim was to compare the respective consequences of intermittent and sustained hypoxia on HIF-1, endothelin-1 and VEGF expression and on cell proliferation and migration in HepG2 liver tumor cells. Wound healing, spheroid expansion, proliferation and migration were evaluated in HepG2 cells following IH or SH exposure. The HIF-1α, endothelin-1 and VEGF protein levels and/or mRNA expression were assessed, as were the effects of HIF-1 (acriflavine), endothelin-1 (macitentan) and VEGF (pazopanib) inhibition. Both SH and IH stimulated wound healing, spheroid expansion and proliferation of HepG2 cells. HIF-1 and VEGF, but not endothelin-1, expression increased with IH exposure but not with SH exposure. Acriflavine prevented the effects of both IH and SH, and pazopanib blocked those of IH but not those of SH. Macitentan had no impact. Thus, IH and SH stimulate hepatic cancer cell proliferation via distinct signaling pathways that may act synergistically in OSA patients with cancer, leading to enhanced tumor progression.

27 February 2026 in Science Advances
Verified
Journal Article
Open access
EMEmilie Montellier
Emilie Montellier
GVGuillaume Vial
Guillaume Vial
SBSophie Bouyon
Sophie Bouyon
KAKousha Changizi Ashtiani
Kousha Changizi Ashtiani
SASherif Abdelkarim
Sherif Abdelkarim
JGJonathan Gaucher
Jonathan Gaucher
Obstructive sleep apnea (OSA), characterized by chronic intermittent hypoxia (IH) during sleep, is increasingly recognized as a driver of metabolic dysfunction. However, its impact on circadian metabolic regulation remains poorly understood. Here, we investigated how chronic IH reshapes 24-hour hepatic and systemic metabolic programs in a mouse model mimicking OSA-associated chronic hypoxia. Through integrated circadian transcriptomic, metabolomic, and physiological 24-hour profiling, we show that 4 weeks of rest phase–restricted IH reprograms hepatic and systemic metabolism in a time-specific manner. This reorganization involves the coordinated circadian regulation of glucose, lipid, and redox pathways, with a shift away from oxidative metabolism toward oxygen-sparing processes such as gluconeogenesis, glycogen turnover, and lipid mobilization. These changes align with the hypoxic phase exposure and coincide with reshaped hepatic metabolite oscillations and systemic autonomic rhythms, supporting a functional adaptation to intermittent oxygen availability. Mechanistically, we identify the cAMP-CREB1 pathway as a driver of circadian transcriptional remodeling in the liver and a central integrator of IH-dependent adrenergic stress. Our findings establish chronic IH as a potent metabolic zeitgeber that rewires hepatic transcriptional and metabolic programs, revealing a circadian dimension to the metabolic consequences of sleep-disordered breathing.

Verified
Journal Article
Open access
PDF file
QBQuentin Boëté
Quentin Boëté
MLMing Lo
Ming Lo
KLKiao-Ling Liu
Kiao-Ling Liu
GVGuillaume Vial
Guillaume Vial
ELEmeline Lemarié
Emeline Lemarié
GFGilles Faury
Gilles Faury
Elastic fibers, made of elastin (90%) and fibrillin-rich microfibrils (10%), are the key extracellular components, which endow the arteries with elasticity. The alteration of elastic fibers leads to cardiovascular dysfunctions, as observed in elastin haploinsufficiency in mice (Eln+/-) or humans (supravalvular aortic stenosis or Williams–Beuren syndrome). In Eln+/+ and Eln+/- mice, we evaluated (arteriography, histology, qPCR, Western blots and cell cultures) the beneficial impact of treatment with a synthetic elastic protein (SEP), mimicking several domains of tropoelastin, the precursor of elastin, including hydrophobic elasticity-related domains and binding sites for elastin receptors. In the aorta or cultured aortic smooth muscle cells from these animals, SEP treatment induced a synthesis of elastin and fibrillin-1, a thickening of the aortic elastic lamellae, a decrease in wall stiffness and/or a strong trend toward a reduction in the elastic lamella disruptions in Eln+/- mice. SEP also modified collagen conformation and transcript expressions, enhanced the aorta constrictive response to phenylephrine in several animal groups, and, in female Eln+/- mice, it restored the normal vasodilatory response to acetylcholine. SEP should now be considered as a biomimetic molecule with an interesting potential for future treatments of elastin-deficient patients with altered arterial structure/function.

29 May 2026 in Comprehensive Physiology
Verified
Journal Article
Open access
PDF file
SPStéphanie Paradis
Stéphanie Paradis
BBBritanny Blachot‐Minassian
Britanny Blachot‐Minassian
SBSophie Bouyon
Sophie Bouyon
ABAntoine Boutin
Antoine Boutin
AMAmel Mohamadi
Amel Mohamadi
Elise BelaïdiElise Belaïdi
Elise Belaïdi
Aim: Chronic intermittent hypoxia (IH), a hallmark of obstructive sleep apnea (OSA), contributes to metabolic diseases and enhances associated cardiovascular (CV) complications through oxidative stress and metabolic alterations. We hypothesize that photobiomodulation (PBM), a non‐invasive low‐level laser therapy, prevents IH‐induced insulin resistance (IR), by preserving insulin signalization and reducing oxidative stress in insulin‐sensitive organs. Methods: Male C57BL/6J mice were randomized in 4 groups, submitted to either 2‐weeks IH (21%–5% FiO 2 , 60 s cycle, 8 h/day) or normoxia (N), with or without PBM (630 nm, 5 J/cm 2 , 32 mW, 120 s, 5 days/week). At day 11, insulin sensitivity was assessed by insulin tolerance test. Then, canonical insulin signaling pathway was explored by western‐blot, and oxidative stress was assessed by measurement of enzymatic activity, O 2 · − content, and lipid and protein oxidation in liver, gastrocnemius (GC) muscle, and epididymal white adipose tissue (eWAT). Results: IH induces systemic IR, impairs insulin signaling in liver and eWAT, and increases hepatic O 2 · − content, while pro/anti‐oxidant enzyme activities were unchanged. Interestingly, in IH group only, PBM significantly improves systemic insulin sensitivity, prevents eWAT insulin signaling alteration and decreases hepatic O 2 · − content. Conclusion: PBM alleviates systemic insulin resistance, restores eWAT insulin signaling, and limits hepatic oxidative stress induced by IH. By enhancing insulin sensitivity, PBM could be proposed as a new therapeutic strategy against OSA‐associated metabolic comorbidities.